Back to Viking Global Investors LP Viking Global Investors LP

NAMS

15 quarters

Position history for Viking Global Investors LPViking Global Investors LP's holdings in NewAmsterdam Pharma Company N.V.

Yes. Viking Global Investors holds 4,203,567 shares of NAMS (NewAmsterdam Pharma), worth $142.5M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Viking Global Investors has held NAMS since Q4 2022, across 15 quarterly 13F filings. NAMS is 0.4% of Viking Global Investors' reported 13F portfolio.

Current Value

$142.5M

Current Shares

4.2M

Total Value Change

+$103M

Total Shares Change

+449,739

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4.2M
0.0%
$142.5M0.4%$33.89
0
2026-Q1
Unchanged
4.2M
0.0%
$134.6M0.4%$32.01
0
2025-Q4
Decreased
4.2M
-35.1%
$147.5M0.4%$35.08
0
2025-Q3
Decreased
6.5M
-7.2%
$184.2M0.5%$28.44
0
2025-Q2
Unchanged
7M
0.0%
$126.4M0.4%$18.11
0
2025-Q1
Unchanged
7M
0.0%
$142.9M0.5%$20.47
0
2024-Q4
Decreased
7M
-13.0%
$179.3M0.6%$25.70
0
2024-Q3
Unchanged
8M
0.0%
$133.2M0.5%$16.60
0
2024-Q2
Unchanged
8M
0.0%
$154.2M0.6%$19.21
0
2024-Q1
Unchanged
8M
0.0%
$189.8M0.7%$23.65
0
2023-Q4
Unchanged
8M
0.0%
$89.6M0.3%$11.17
0
2023-Q3
Increased
8M
+23.0%
$74.2M0.3%$9.25
43
2023-Q2
Increased
6.5M
+66.6%
$77.6M0.3%$11.89
52
2023-Q1
Increased
3.9M
+4.3%
$52.6M0.2%$13.26
37
2022-Q4
New
3.8M
-
$39.5M0.2%$10.90
48

Other major holders of NAMS: Capital World Investors, FMR LLC, RA Capital Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used